Bayesian Capital Management LP Increases Position in Celsius Holdings, Inc. (NASDAQ:CELH)

Bayesian Capital Management LP lifted its position in shares of Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) by 110.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 30,484 shares of the company's stock after buying an additional 15,984 shares during the quarter. Bayesian Capital Management LP's holdings in Celsius were worth $803,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of CELH. Janney Montgomery Scott LLC boosted its stake in shares of Celsius by 85.4% in the fourth quarter. Janney Montgomery Scott LLC now owns 58,178 shares of the company's stock worth $1,532,000 after acquiring an additional 26,801 shares during the period. Diversified Trust Co bought a new stake in shares of Celsius during the fourth quarter valued at approximately $869,000. Bennett Selby Investments LP raised its position in shares of Celsius by 392.6% during the fourth quarter. Bennett Selby Investments LP now owns 51,645 shares of the company's stock valued at $1,360,000 after buying an additional 41,161 shares during the last quarter. Annex Advisory Services LLC bought a new position in shares of Celsius during the fourth quarter worth $1,165,000. Finally, Mirae Asset Global Investments Co. Ltd. grew its stake in Celsius by 5.1% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 22,689 shares of the company's stock valued at $587,000 after acquiring an additional 1,100 shares in the last quarter. Hedge funds and other institutional investors own 60.95% of the company's stock.

Celsius Price Performance

Shares of NASDAQ:CELH opened at $33.89 on Tuesday. The business has a 50 day simple moving average of $33.20 and a two-hundred day simple moving average of $29.54. Celsius Holdings, Inc. has a 1 year low of $21.10 and a 1 year high of $98.85. The firm has a market capitalization of $8.73 billion, a PE ratio of 77.02, a price-to-earnings-growth ratio of 2.90 and a beta of 1.65.

Celsius (NASDAQ:CELH - Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.11 by $0.03. Celsius had a return on equity of 51.89% and a net margin of 10.70%. The company had revenue of $332.20 million for the quarter, compared to the consensus estimate of $326.07 million. Equities research analysts expect that Celsius Holdings, Inc. will post 0.89 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

CELH has been the topic of several research analyst reports. Stifel Nicolaus decreased their price target on shares of Celsius from $45.00 to $37.00 and set a "buy" rating on the stock in a research note on Monday, February 10th. Truist Financial raised Celsius from a "hold" rating to a "buy" rating and increased their price target for the company from $35.00 to $45.00 in a research note on Monday, March 31st. JPMorgan Chase & Co. lifted their price objective on Celsius from $39.00 to $44.00 and gave the stock an "overweight" rating in a research note on Friday. B. Riley reiterated a "buy" rating and set a $49.00 target price (up from $44.00) on shares of Celsius in a research report on Friday, February 21st. Finally, Needham & Company LLC boosted their price target on shares of Celsius from $40.00 to $45.00 and gave the stock a "buy" rating in a research report on Wednesday, April 9th. One analyst has rated the stock with a sell rating, four have issued a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $46.88.

Insider Buying and Selling

In other news, insider Paul H. Storey sold 10,188 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $25.77, for a total transaction of $262,544.76. Following the transaction, the insider now owns 45,297 shares of the company's stock, valued at approximately $1,167,303.69. This represents a 18.36 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Joyce Russell sold 4,000 shares of Celsius stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total value of $113,880.00. Following the completion of the sale, the director now owns 19,106 shares of the company's stock, valued at $543,947.82. The trade was a 17.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by insiders.

Celsius Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.